Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Publications
(up to ten in the last five years)
Last Updated 9/24/2020
Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity
Heliyon
Volume: 4
Date: 09 2018
10.1016/j.heliyon.2018.e00795
Relationship of Pulmonary Outcomes, Microbiology, and Serum Antibiotic Concentrations in Cystic Fibrosis Patients.
J Pediatr Pharmacol Ther
Volume: 23
Date: 09 2018
10.5863/1551-6776-23.5.379
Microbial diversity within the airway microbiome in chronic pediatric lung diseases
Infect Genet Evol
Volume: 63
Date: 09 2018
10.1016/j.meegid.2017.12.006
Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis
Sci Rep
Volume: 9
Date: 02 2019
10.1038/s41598-019-38984-y
Profile of the Pediatric Infectious Disease Workforce in 2015.
J Pediatric Infect Dis Soc
Volume: 8
Date: 03 2019
10.1093/jpids/pix094
Bacterial Community Variability: Outliers May Be Leading Us Astray
Ann Am Thorac Soc
Volume: 16
Date: 12 2019
10.1513/AnnalsATS.201909-716ED
Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study.
Front Cell Infect Microbiol
Volume: 10
Date: 04 2020
10.3389/fcimb.2020.00174
Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation
Heliyon
Volume: 4
Date: 06 2020
10.1016/j.heliyon.2020.e04104. eCollection 202
Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region
J Pediatric
Volume: 223
Date: 08 2020
10.1016/j.jpeds.2020.05.007
Reducing Vancomycin Use in a Level IV Neonatal Intensive Care Unit
Pediatrics
Volume: 146
Date: 08 2020
10.1542/peds.2019-2963